Global Genomics Based Personalized Wellness Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Genomics Based Personalized Wellness Market Analysis

  • Medical Devices
  • Jul 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • Genomics-based personalized wellness solutions, which offer DNA-driven insights into fitness, nutrition, disease risk, and lifestyle optimization, are increasingly becoming central to preventive healthcare and individualized wellness strategies across both consumer and professional healthcare settings. These solutions enhance the ability to make informed health decisions by providing users with customized recommendations based on their unique genetic profiles
  • The rising demand for personalized wellness is primarily fueled by increasing awareness of preventive health, decreasing costs of genomic sequencing, and growing interest in data-driven, personalized lifestyle management. Consumers are increasingly prioritizing longevity, chronic disease prevention, and tailored interventions making genomics-based tools highly attractive
  • North America dominated the genomics-based personalized wellness market with the largest revenue share of 38.9% in 2024, supported by widespread availability of consumer genomic services, advanced healthcare infrastructure, and a highly engaged wellness-conscious population. The U.S. leads this trend with robust demand for DTC testing kits and the integration of AI-powered health platforms offering personalized insights
  • Asia-Pacific is expected to be the fastest-growing region in the market during the forecast period due to increasing healthcare digitization, rising health awareness, and expanding middle-class populations investing in wellness solutions
  • The predictive testing segment dominated the market with a share of 45.2% in 2024, driven by its application in identifying genetic risks for conditions such as diabetes, cancer, and heart disease empowering consumers and clinicians to take early preventive action

Filled Map Analysis